FONT-SIZE Plus   Neg

Roche Q1 Group Sales Rise; Backs 2012 Outlook - Quick Facts

Roche Holding AG (RHHBY.PK) said its first-quarter group sales rose 2% at constant exchange rates to 11.03 billion Swiss francs from a year ago. Excluding Tamiflu, sales growth is 3%. Sales were down 1% in Swiss francs, while it was up 1% in US dollars.

Roche also confirmed its full-year outlook for 2012. Barring unforeseen events, Roche still expects low to mid-single-digit sales growth at constant exchange rates for the Group and the Pharmaceuticals Division in 2012.

Despite a challenging market environment, based on the expected sales growth and continued efficiency improvements, Roche continues to aim for a high single-digit increase in Core Earnings per Share at constant exchange rates.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

comments powered by Disqus
Follow RTT